Skip to content
lifestyle.smarttalksuccess.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Quantum BioPharma
Quantum Biopharma Announces Appointment of Principal Investigator for Planned Phase 2 Clinical Trial of Lucid-21-302 (Lucid-MS) in Multiple Sclerosis
May 1, 2026
Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd
May 1, 2026
Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering
April 30, 2026
Quantum BioPharma Provides Corporate Update
April 29, 2026
Quantum BioPharma Provides Corporate Update
April 29, 2026
←
Previous Page
1
2